The advantages of a gonadotropin releasing hormone agonist (leuprolide acetate) in conjunction with gonadotropins for controlled ovarian hyperstimulation in IVF and GIFT cycles.
Kerin
J F
JF
Centre for Reproductive Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine.
D000328:Adult; D006063:Chorionic Gonadotropin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D005260:Female; D005307:Fertilization in Vitro; D005500:Follow-Up Studies; D015181:Gamete Intrafallopian Transfer; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage; D006801:Humans; D007247:Infertility, Female / Q000628:therapy*; D016729:Leuprolide; D008596:Menotropins / Q000008:administration & dosage*; D011247:Pregnancy; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic
D006063:Chorionic Gonadotropin; D007987:Gonadotropin-Releasing Hormone; D008596:Menotropins; D016729:Leuprolide